Abstract
There has been a great deal of interest recently in genetic effects on neurocognitive performance in the healthy population. KIBRA –a postsynaptic protein from the WWC family of proteins– was identified in 2003 in the human brain and kidney and has recently been associated with memory performance and synaptic plasticity. Through genome-wide screening, a single nucleotide polymorphism (SNP) was detected in the ninth intron of KIBRA gene (T→ C substitution) and was implicated in human memory and the underlying neuronal circuitry. This review presents a synopsis of the current findings on the effects of the KIBRA SNP on human memory and synaptic plasticity. Overall the findings suggest impaired memory performance and less efficient or impaired hippocampal/medial temporal lobe (MTL) activation in CC homozygotes (in comparison to T carriers) with some differences between young and older subjects. This review also highlights limitations and potential sources for variability of studies’ imaging findings along with future perspectives and implications for the role of KIBRA in memory-related brain systems.
Keywords: Cognition, episodic memory, fMRI, genetic polymorphism, KIBRA, synaptic plasticity.
Current Neuropharmacology
Title:Effects of the KIBRA Single Nucleotide Polymorphism on Synaptic Plasticity and Memory: A Review of the Literature
Volume: 12 Issue: 3
Author(s): Laetitia C. Schwab, Vincent Luo, Chelsey L. Clarke and Pradeep J. Nathan
Affiliation:
Keywords: Cognition, episodic memory, fMRI, genetic polymorphism, KIBRA, synaptic plasticity.
Abstract: There has been a great deal of interest recently in genetic effects on neurocognitive performance in the healthy population. KIBRA –a postsynaptic protein from the WWC family of proteins– was identified in 2003 in the human brain and kidney and has recently been associated with memory performance and synaptic plasticity. Through genome-wide screening, a single nucleotide polymorphism (SNP) was detected in the ninth intron of KIBRA gene (T→ C substitution) and was implicated in human memory and the underlying neuronal circuitry. This review presents a synopsis of the current findings on the effects of the KIBRA SNP on human memory and synaptic plasticity. Overall the findings suggest impaired memory performance and less efficient or impaired hippocampal/medial temporal lobe (MTL) activation in CC homozygotes (in comparison to T carriers) with some differences between young and older subjects. This review also highlights limitations and potential sources for variability of studies’ imaging findings along with future perspectives and implications for the role of KIBRA in memory-related brain systems.
Export Options
About this article
Cite this article as:
C. Schwab Laetitia, Luo Vincent, L. Clarke Chelsey and J. Nathan Pradeep, Effects of the KIBRA Single Nucleotide Polymorphism on Synaptic Plasticity and Memory: A Review of the Literature, Current Neuropharmacology 2014; 12 (3) . https://dx.doi.org/10.2174/1570159X11666140104001553
DOI https://dx.doi.org/10.2174/1570159X11666140104001553 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Polyphenols as Potential Therapeutics for Pain and Inflammation in Spinal Cord Injury
Current Molecular Pharmacology Cholesterol Homeostasis Failure in the Brain: Implications for Synaptic Dysfunction and Cognitive Decline
Current Medicinal Chemistry Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities
Current Neuropharmacology Editorial (Thematic Issue: Health Impact and Management of a Disrupted Circadian Rhythm and Sleep in Critical Illnesses)
Current Pharmaceutical Design L-Type Voltage-Dependent Calcium Channels As Therapeutic Targets for Neurodegenerative Diseases
Current Medicinal Chemistry Hormonal Control of the Neuropeptide Y System
Current Protein & Peptide Science Dampening the Progression of Dementia
Current Neurovascular Research Possible Involvement of Muscarinic Receptors in Psychiatric Disorders: A Focus on Schizophrenia and Mood Disorders
Current Molecular Medicine Parkinsons Disease: Genetics and Beyond
Current Neuropharmacology A New Glucocorticoid Hypothesis of Brain Aging: Implications for Alzheimers Disease
Current Alzheimer Research Leukocyte-mediated Tissue Injury in Ischemic Stroke
Current Medicinal Chemistry Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development
Current Topics in Medicinal Chemistry The Pro-Apoptotic Substance Thapsigargin Selectively Stimulates Re-Growth of Brain Capillaries
Current Neurovascular Research Application of Sulfamic Acid in Organic Synthesis-A Short Review
Current Organic Chemistry Preface: Developments in Understanding of Alzheimer Disease
Current Alzheimer Research Berberine Ameliorates Cognitive Impairment by Regulating Microglial Polarization and Increasing Expression of Anti-inflammatory Factors following Permanent Bilateral Common Carotid Artery Occlusion in Rats
CNS & Neurological Disorders - Drug Targets Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Pharmacogenetics in Geriatric Medicine: Challenges and Opportunities for Clinical Practice
Current Drug Metabolism Genetic Signatures in the Treatment of Stroke
Current Pharmaceutical Design Unraveling the Action Mechanism of Buyang Huanwu Tang (BYHWT) for Cerebral Ischemia by Systematic Pharmacological Methodology
Combinatorial Chemistry & High Throughput Screening